Keloids: what do we know and what do we do next?

Transl Res. 2012 Mar;159(3):173-4. doi: 10.1016/j.trsl.2011.11.007. Epub 2011 Dec 17.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Animals
  • Endostatins / metabolism*
  • Endostatins / therapeutic use*
  • Female
  • Humans
  • Keloid / drug therapy*
  • Keloid / metabolism*
  • Male
  • Neovascularization, Pathologic / drug therapy*
  • Neovascularization, Pathologic / metabolism*
  • Vascular Endothelial Growth Factor A / metabolism*

Substances

  • Angiogenesis Inhibitors
  • Endostatins
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A